HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Douketis, J. D Search for Related Content PubMed Articles by Douketis, J. D

Review: counselling, pharmacotherapy, and surgery help obese adults lose weight

Clinical impact ratings GP/FP/Primary care IM/Ambulatory care Cardiology Endocrine Geriatrics

Key Words: behaviour therapy • counselling • obesity • orlistat • sibutramine • surgery

The first 150 words of the full text of this article appear below.

METHODS
Data sources: Medline, the Cochrane Library, and systematic reviews from the US, Canada, and the UK.

Study selection and assessment: randomised controlled trials (RCTs) or systematic reviews of screening and treatment for obesity. Drug treatment studies had to have 6 months of follow up; all other treatments had to have 12 months of follow up. Study quality was assessed using the US Preventive Services Task Force criteria.

Outcome: weight loss.

MAIN RESULTS
No RCTs evaluated the efficacy of obesity screening. Counselling and behavioural interventions. 3 systematic reviews showed that behavioural interventions promoting exercise and/or dietary change achieved small weight reductions (US: 29 RCTs, mean weight change over controls –3.3 kg, range –8.8 to 1.9 at 1 y) (UK: 24 RCTs, mean weight change over controls –3.0, range –10.6 to 1.4 at 12–60 mo) (Canada: 6 RCTs, mean weight change over controls –2.1, range –4.5 to –0.2 at 24–84 mo). Of 11 . . . [Full text of this article]

James D Douketis, MD, FRCP(C)

St Joseph’s Hospital
Hamilton, Ontario, Canada